Dermira Stock Price - DERM

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 7.62 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Dermira Inc DERM NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.09 1.2% 7.62 7.72 7.431 7.61 7.53 19:59:41
Bid Price Ask Price Spread Spread % News
7.01 9.00 1.99 22.11% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,774 777,463 $ 7.61 $ 5,918,051 1,662,738 5.25 - 15.48
Last Trade Time Type Quantity Stock Price Currency
18:17:12 1 $ 7.61 USD

Dermira Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 415.45M 54.52M $ -221.54M -5.27 - 54.19M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 20.00 0.60%

more financials information »

Dermira News

Date Time Source News Article
11/14/201916:05Business WireDermira Presents New Scientific Research Findings from the..
11/13/201917:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/13/201917:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/13/201917:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
11/13/201917:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
11/13/201916:22Edgar (US Regulatory)Current Report Filing (8-k)
11/13/201916:05Business WireDermira Elects Halley E. Gilbert to its Board of Directors

Latest DERM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DERM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.519.397.258.142,513,223-0.89-10.46%
1 Month5.809.395.807.372,103,0181.8231.38%
3 Months8.929.485.257.251,160,050-1.30-14.57%
6 Months10.3310.825.257.99872,882-2.71-26.23%
1 Year9.7415.485.259.911,140,146-2.12-21.77%
3 Years35.2038.755.2513.96815,301-27.58-78.35%
5 Years16.0038.755.2515.45551,109-8.38-52.38%

Dermira Description

Dermira Inc is a biopharmaceutical company focuses on the development and commercialization of medical dermatology products to dermatologists and their patients primarily in the United States.The company's late-stage product candidates include Cimzia, an injectable biologic tumor necrosis factor-alpha inhibitor to treat various inflammatory diseases, as well as to treat patients with moderate-to-severe chronic plaque psoriasis; Glycopyrronium tosylate, a small-molecule anticholinergic product that is in Phase III clinical trial for the treatment of primary axillary hyperhidrosis or excessive underarm sweating; and Olumacostat glasaretil, a small-molecule sebum inhibitor, which is in Phase III clinical trial to treat acne vulgaris or acne.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191117 22:58:01